FDA Approves Qinlock ripretinib for FourthLine Treatment of AGST

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> COPY / PASTE LINK PLEASE 🎵 MP3 <<

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=S9WiptrwQxQ

U.S. Food and Drug Administration approved Qinlock (ripretinib) tablets as the first new drug specifically approved as a fourth-line treatment for advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. Qinlock is indicated for adult patients who have received prior treatment with three or more kinase inhibitor therapies, including imatinib. • =========================== • Join our telegram group : https://t.me/pharmd_official • Download PharmD app from Playstore now.. • Exclusively developed for PharmDianz • App link : http://bit.ly/pharmdapp • Pharmacon -The best ever app for Pharmacological Drug Classification • App link : https://bit.ly/pharmaconapp • #FDA #Qinlock #ripretinib

#############################